Embrace the Sessions
Choose from a variety of panel discussions developed by industry partners and facilitated by expert moderators on topics that matter most to you.
Monday, May 6 | 2:30 – 4:20 p.m.
The InterGrowth experience extends beyond the networking and deal flow opportunities with dynamic programming that gives you access to all of the latest trends, best practices and industry insights.
Breakout sessions will take place from 2:30 – 3:20 p.m. and 3:30 – 4:20 p.m. on Monday, May 6.
2:30 – 3:20 p.m.
International Growth, Accelerated: Reduce Operational Risk and Increase ROI
Join us for a discussion that answers critical questions that can make or break an international expansion. We’ll explore four common employment paths—establishing a legal entity, hiring independent contractors, using a non-resident employer, or utilizing an Employer of Record— and which ones are best to help reduce operational risk and increase ROI.
- Rob Wellner, Senior Vice President of Sales, Velocity Global
- John Pennett, Partner, Life Sciences and Technology Group, EisnerAmper LLP
Sponsored By Velocity Global
The State of the Middle Market
Representing nearly 200,000 American companies in every industry nationwide, the US middle market is a force driving economic growth. With annual revenues ranging from $10 million to $1 billion, middle-market firms collectively generate one-third of the US private sector. Join us for an interactive panel discussion where we discuss the ins and outs of the US middle market.
- Bruce Hernandez, General Partner, Spire Capital
- John Newman, Principal, Capital Partners
- Don Rawe, Partner, BKD
- Moderated by Paul Gajer, Partner, Dentons
Sponsored By Dentons
Wayfair Sparks New Complexities in M&A
When the U.S. Supreme Court ruled to remove the physical presence test as a requirement to impose sales tax nexus in South Dakota v. Wayfair, it introduced new complexities into the M&A deal process. Due diligence is now more critical than ever, considering the peril when a deal target has historic nexus and exposures. Join the panel discussion to learn more about your responsibility as a buyer, your past exposure as a seller and how to navigate your negotiations.
- Meghan Jodz, Partner, Tax Services, Grant Thornton LLP
- Garrett Schires, Principal, Sentinel Capital Partners
- Mark Yopp, Partner, McDermott Will & Emery
- Moderated by Chris Schenkenberg, National Managing Partner, M&A Tax Services, Grant Thornton LLP
Sponsored By Grant Thornton
Trends in the Healthy Living Space
The healthy living industry started gaining pace in the early 80s sparked by American Icons Jane Fonda and Richard Simmons who were leading aerobics while rocking leg warmers and sweating to the oldies. Fast forward to 2019. Healthy living, the former niche market, is a $1.2 trillion mainstream industry that has experienced rapid growth. This growth is directly correlated to consumers’ interest in products and services that make them feel healthier, fitter and more active, all leading to better overall wellness. Join our panel of GPs, investment bankers, and advisers offering real-world insight on how the healthy living industry will continue to yield healthy investor returns.
- Charlie Hurt, Managing Director, Fifth Third bank
- Hemanshu Patel, Principal, North Castle Partners
- John McKee, Managing Director, PWP Growth
- John Ruckstuhl, Managing Director, EisnerAmper
- Moderated by Ethan Boothe, Principal, EisnerAmper PE Industry Leader
Sponsored By EisnerAmper LLP
3:30 – 4:20 p.m.
State of M&A: Impact of Potential Disruptors on Market Activity in 2019 and Beyond
In today’s marketplace, strong economic fundamentals and increasing sector convergence is fueling U.S. dealmaking, and this trend of robust M&A activity is expected to continue. However, the M&A market could experience disruptions and uncertainty, both domestically and across the globe, which will cause organizations to reassess their acquisition strategies. Join us for an interactive panel discussion where our panelists will share thoughts on how potential disruptors may affect M&A activity for the rest of 2019 and beyond.
- Tony Nitti, Partner, RubinBrown LLP
- Tom Aronson, Partner, Head of Originations, Monroe Capital
- Chris Willis, Director, Industrial Opportunity Partners
- Moderated by Michael Milani, Executive Managing Director and Principal, Baker Tilly Capital, LLC
Sponsored By Baker Tilly
Healthcare Provider-Type Acquisitions: Regulatory Pitfalls Affecting PE Firms
There recently has been a resurgence of acquisitions by private equity firms in the healthcare provider space due to several fundamental factors. Innovation, an aging population, and a fragmented delivery system are driving disruption, consolidation and increased growth within the industry. Private equity investors need to understand how to avoid and manage the various pitfalls related to such an environment. Be sure to join our interactive discussion on how to best to perform your diligence and avoid such pitfalls.
- Kolin Holladay, Corporate and Transactional Attorney, Polsinelli PC
- Jason Mangus, Vice President of Strategic/Corporate Development, United Surgical Partners International, Inc.
- Lee Bentley, Partner, Bradley PC
- Moderated by Wayne Pryor, Managing Director, Transaction Services, BKD
Sponsored By BKD
Rationalization of EBITDA Add-backs and Impact on Recoveries
EBITDA adjustments, or add-backs, have been a hot topic in the leveraged finance market in recent years, as sustained investor demand for loans has further enabled aggressive deal structures, pushing overall leverage higher. Please join us at InterGrowth where panelists will discuss how common add-backs are, as well as how large they have become, and then take an honest look at how much riskier these deals are and what the potential impact will be on recoveries when default rates rise.
- Randy Schwimmer, Senior Managing Director, Head of Origination & Capital Markets, Churchill Asset Management LLC
- Justin Abelow, Managing Director, Houlihan Lokey
- John Liguori, Chief Investment Officer – Jefferies Finance Direct Lending, Jefferies Finance
- Moderated by Ruth Yang, Managing Director, S&P Global Market Intelligence
Sponsored By S&P Global
The Importance of Intellectual Property in Your Next Deal
Join us for a discussion on the impact of intellectual property protection on the value of a deal, addressing patents, trademarks, copyrights, and trade secrets in the context of the pharmaceutical, biotech, high tech and software industries. We will explore what companies and investors should look for in intellectual property when seeking to acquire a technology or life science asset, how to best position and reinforce intellectual property when seeking a potential M&A or licensing deal, and where to find intellectual property red flags in an M&A or licensing transaction.
- Kevin McCabe, Associate General Counsel, TherapeuticsMD
- Andrew Chien, Executive Director, Senior Counsel, Intellectual Property, Allergan
- Ha Kung Wong, Partner, Venable
- Moderated by Lindsay Monti, Counsel, Venable
Sponsored By Venable